Maternal exposure to picrotoxin modifies the response of the GABA(A) receptor during sexual behavior of adult male rat offspring


Autoria(s): Bernardi, Maria M.; Kirsten, Thiago B.; Teodorov, Elizabeth; Baso, Ana C. Z.; Prosdocimi, Fabio C.; Felicio, Luciano F.
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

23/10/2013

23/10/2013

2012

Resumo

This study investigated whether perinatal exposure to picrotoxin, a GABA(A) antagonist, modifies the effect of muscimol, a GABA(A) agonist, on the sexual behavior of adult male rats. Two hours after birth and then once daily during the next 9 days of lactation, dams received picrotoxin (0.75 mg/kg subcutaneously) or saline (1 ml/kg subcutaneously). The adult male offspring from the picrotoxin and saline groups received saline (1 ml/kg intraperitoneally) or muscimol (1 mg/kg intraperitoneally), and 15 min later, their sexual behavior was assessed. Muscimol treatment in the saline-exposed group increased the mount and intromission latencies. However, these effects were absent in the picrotoxin-exposed groups. The latencies to first ejaculation, postejaculatory mount, and intromission were decreased in both picrotoxin-exposed groups relative to the saline-exposed groups. The picrotoxin + muscimol-treated rats required more intromissions to ejaculate and the picrotoxin-exposed groups made more ejaculations than the saline-exposed groups. Thus, muscimol treatment did not increase the mount and intromission latencies following picrotoxin exposure, but increased the ejaculation frequency, which did not differ between the picrotoxin + muscimol and the picrotoxin + saline groups. These data indicate that perinatal picrotoxin treatment interfered with GABA(A) receptor development Behavioural Pharmacology 23:703-709 (c) 2012 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.

Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [96/04273-4, 06690-1]

Fundacao de Amparo a Pesquisa do Estado de Sao Paulo

Conselho Nacional de Desenvolvimento Cientifico e Tecnologico

Conselho Nacional de Desenvolvimento Cientifico e Tecnologico

Maria Martha Bernardi [352189/96-7]

Maria Martha Bernardi

Identificador

BEHAVIOURAL PHARMACOLOGY, PHILADELPHIA, v. 23, n. 7, supl. 1, Part 3, pp. 703-709, OCT, 2012

0955-8810

http://www.producao.usp.br/handle/BDPI/35741

10.1097/FBP.0b013e3283586072

http://dx.doi.org/10.1097/FBP.0b013e3283586072

Idioma(s)

eng

Publicador

LIPPINCOTT WILLIAMS & WILKINS

PHILADELPHIA

Relação

BEHAVIOURAL PHARMACOLOGY

Direitos

restrictedAccess

Copyright LIPPINCOTT WILLIAMS & WILKINS

Palavras-Chave #BRAIN DEVELOPMENT #GAMMA-AMINOBUTYRIC ACID #LACTATION #MUSCIMOL #PERINATAL PERIOD #PICROTOXIN #RAT #SEXUAL BEHAVIOR #SUBUNIT MESSENGER-RNAS #POSTNATAL-DEVELOPMENT #LOCOMOTOR-ACTIVITY #PRENATAL EXPOSURE #DIAZEPAM EXPOSURE #MOTOR EXECUTION #BRAIN #FETAL #EXPRESSION #DIPHENHYDRAMINE #BEHAVIORAL SCIENCES #NEUROSCIENCES #PHARMACOLOGY & PHARMACY
Tipo

article

original article

publishedVersion